| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.68B | 19.40B | 18.90B | 17.82B | 15.36B | 13.06B |
| Gross Profit | 3.52B | 3.77B | 3.88B | 3.07B | 2.58B | 1.82B |
| EBITDA | 2.58B | 3.05B | 3.27B | 2.45B | 1.70B | 946.10M |
| Net Income | 1.16B | 2.18B | 1.66B | 745.00M | 1.19B | 235.91M |
Balance Sheet | ||||||
| Total Assets | 16.21B | 19.33B | 17.88B | 16.95B | 15.66B | 11.84B |
| Cash, Cash Equivalents and Short-Term Investments | 2.50B | 4.19B | 3.90B | 2.53B | 1.85B | 1.09B |
| Total Debt | 3.07B | 1.45B | 1.95B | 1.78B | 2.53B | 313.52M |
| Total Liabilities | 6.31B | 5.17B | 5.56B | 6.20B | 5.51B | 2.76B |
| Stockholders Equity | 9.90B | 14.15B | 12.32B | 10.75B | 10.15B | 9.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.09B | 2.14B | 599.00M | 993.84M | -275.74M |
| Operating Cash Flow | 0.00 | 3.22B | 3.38B | 2.52B | 1.84B | 635.35M |
| Investing Cash Flow | 0.00 | -2.26B | -1.28B | -1.82B | -784.90M | -905.44M |
| Financing Cash Flow | 0.00 | -663.00M | -722.00M | -19.00M | -961.10M | -532.23M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥25.63B | 6.45 | ― | 2.45% | 21.60% | 116.17% | |
75 Outperform | ¥60.44B | 4.62 | ― | 2.44% | 5.74% | 76.28% | |
71 Outperform | ¥65.20B | 13.32 | ― | 3.98% | 1.21% | -14.59% | |
70 Neutral | ¥92.32B | 7.70 | ― | 3.59% | 4.55% | 79.33% | |
69 Neutral | ¥187.18B | 13.74 | ― | 1.65% | 4.90% | -19.32% | |
63 Neutral | ¥57.88B | 22.47 | ― | 0.34% | 4.70% | -2.58% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |